Key facts
- Notable investors include Central Texas Angel Network, Neuvation Ventures, Riptide Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for NeuroIntact
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroIntact are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroIntact
Manufacturer of a brain-cooling medical device intended for patients suffering from traumatic brain injury, stroke, or elevated intracranial pressure. The company's platform develops a targeted temperature management system that enables non-invasive intranasal cooling of the brain to reduce swelling and manage core temperature without systemic side-effects, enabling hospitals and critical-care providers to offer neuroprotection and improved outcomes in neurological emergencies.
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2016
- Employees
- 7
- Website
- neurointact.com/
- Ownership
- Privately Held (backing)
NeuroIntact doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroIntact shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroIntact in its N-PORT filings yet. We sweep new filings monthly.